AN2 Therapeutics (ANTX) Treasury Shares (2021 - 2025)
AN2 Therapeutics' (ANTX) quarterly Treasury Shares came in at $856160.0 in Q4 2025, up 65.76% year-on-year from $516511.0 in Q4 2024, and down 7.69% on a QoQ basis from $927468.0 in Q2 2025.
AN2 Therapeutics (ANTX) Treasury Shares (2021 - 2025) Analysis & Trends
AN2 Therapeutics (ANTX) has 3 years of Treasury Shares data on file, last reported at $856160.0 in Q4 2025.
- On a quarterly basis, Treasury Shares rose 65.76% year-over-year to $856160.0 in Q4 2025; TTM through Dec 2025 was $856160.0, a 65.76% increase from a year earlier, with the FY2025 full-year figure at $856160.0, up 65.76% from the prior year.
- Treasury Shares for Q4 2025 stood at $856160.0, down from $927468.0 in the prior quarter.
- Over the last five years, Treasury Shares for ANTX reached as high as $11.4 million in Q1 2021 and fell as low as $458246.0 in Q1 2024.
- Historically, Treasury Shares has averaged $4.6 million across 3 years, with a median of $923664.0 in 2025.
- On a YoY basis, Treasury Shares climbed as much as 101.57% in 2025 and fell as far as 48.46% in 2025.
- Year by year, Treasury Shares stood at $11.4 million in 2021, then slumped by 95.47% to $516511.0 in 2024, then jumped by 65.76% to $856160.0 in 2025.
- Per Business Quant data, the three most recent Treasury Shares figures were $856160.0 in Q4 2025, $927468.0 in Q2 2025, and $923664.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | AN2 Therapeutics | 167.57 Mn | 167.57 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 856,160.00 |
| Dec 31, 2025 | 856,160.00 |
| Jun 30, 2025 | 927,468.00 |
| Jun 30, 2025 | 927,468.00 |
| Mar 31, 2025 | 923,664.00 |
| Mar 31, 2025 | 923,664.00 |
| Dec 31, 2024 | 516,511.00 |
| Dec 31, 2024 | 516,511.00 |
| Sep 30, 2024 | 470,809.00 |
| Sep 30, 2024 | 470,809.00 |
| Jun 30, 2024 | 624,719.00 |
| Jun 30, 2024 | 624,719.00 |
| Mar 31, 2024 | 458,246.00 |
| Mar 31, 2024 | 458,246.00 |
| Dec 31, 2021 | 11.41 Mn |
| Dec 31, 2021 | 11.41 Mn |
| Sep 30, 2021 | 11.41 Mn |
| Sep 30, 2021 | 11.41 Mn |
| Jun 30, 2021 | 11.41 Mn |
| Jun 30, 2021 | 11.41 Mn |